Welcome to the UCL Cancer Institute
The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing better, more effective treatments to improve outcomes for cancer patients. If you are considering postgraduate study with us, applications to our flagship MSc Cancer programme are open until 29th July 2016 for September entry.
An international research collaboration led by UCL scientists has developed ways to improve the quality and accuracy of information harvested from epigenome sequencing datasets in two new research papers published jointly in Nature Biotechnology and Nature Communications today. According to the studies, epigenome sequencing technologies can allow for more comprehensive analysis of cancers - a key component in the development of targeted approaches to combat cancer.
Published: Jun 27, 2016 5:09:23 PM
The final stages of an £8.9 million award to advance cancer medical research facilities at UCL/UCLH, were celebrated last night with a launch event marking the implementation of new cancer genomics and imaging technologies that will support two world-class cancer research programmes. The event, hosted at the UCL Cancer Institute, featured keynote speeches from Dr Jim Smith, MRC Deputy Chief Executive and Chief of Strategy and Professors Mark Emberton, Tim Meyer and Tariq Enver, who will be leading the research projects at UCLH and UCL.
Published: Jun 16, 2016 3:16:06 PM
Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition in mice at UCL and King’s College London, according to a new study published in Cell Reports. Researchers are investigating the potential of using the treatment in a number of other auto-inflammatory conditions.
Published: Jun 13, 2016 3:13:44 PM
Dr Martin Pule has been named BBSRC Most Promising Innovator 2016 for his frontier innovations in T-cell medicine. The competition is designed to recognise the full breadth of BBSRC-funded research and rewards individuals and small teams who have harnessed the potential of their excellent research.
Published: May 20, 2016 11:43:27 AM
Professor Heather Payne, Consultant in Clinical Oncology, UCLH and Professor Gary Royle, UCL Dept. of Medical Physics and Biomedical Engineering, present this seminar on research and developments in radiotherapy. Thursday 30th June, 12pm.
Starts: Jun 30, 2016 12:00:00 PM
A free one-day medical education meeting for healthcare professionals that brings together Haematology experts from UCL and beyond. Chaired by Professors Tariq Enver and Adele Fielding. Friday 1 July, 9.00am - 4.30pm. View programme and register for your place.
Starts: Jul 1, 2016 9:00:00 AM
Join Dr Joanne McDonald and Dr Gareth Gerrard as they host an introductory seminar on the Biobank and Pathology Core Facilities available at UCL/UCLH, Friday 1st July 10.00 - 11.00am.
Starts: Jul 1, 2016 10:00:00 AM
Join clinical researcher and consultant Dr Beth Payne in web chat session: Managing myelodysplastic syndromes (MDS) from diagnosis to treatment, Wednesday 6 July 12.00- 1.00pm.
Starts: Jul 6, 2016 12:00:00 PM
Support our work
The progress we make in understanding and developing treatments for cancer is made possible by the generous support of individuals, companies and charitable trusts and foundations. Our donors support us every step of the way in the ongoing fight against cancer.
Find out more about how you can help us to continue research that will lead to breakthroughs in cancer therapies and benefit the lives of cancer patients.